| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||||||
Net income | ||||||||||
22,748 | 305,193 | 477,190 | 526,963 | 462,490 | 457,707 | 425,110 | -235,011 | -54,956 | - | - |
Net loss | ||||||||||
- | - | - | - | - | - | - | - | - | - | -31,908 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||||
Deferred tax liabilities | ||||||||||
-107,402 | - | - | - | 179,658 | - | - | - | - | - | - |
Interest earned on investments and marketable securities held in Trust Account | ||||||||||
-638,910 | -6,265,842 | 892,595 | 2,834,408 | -934,689 | - | - | - | - | - | 0 |
Changes in operating assets and liabilities: | ||||||||||
Prepaid expenses | ||||||||||
-218,073 | 24,430 | 475,788 | -261,815 | 22,460 | - | - | - | - | - | 0 |
Accounts payable | ||||||||||
245,356 | -1,132 | -20,624 | -47,758 | 82,738 | 40,782 | 6,204 | -25,274 | -7,680 | -1,110 | 28,228 |
Accrued expenses | ||||||||||
4,390 | 21,610 | -679 | -15,321 | 18,500 | -141,739 | 25,739 | 122,500 | -13,600 | 10,600 | 3,000 |
Franchise tax payable | ||||||||||
-10,050 | 330,000 | 10,000 | -330,000 | 150,000 | - | - | - | - | - | - |
Deferred tax liability | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Net cash used in operating activities | ||||||||||
-245,695 | -419,165 | -448,848 | -725,340 | -363,763 | -271,505 | -386,339 | -196,951 | -76,236 | -81,185 | -680 |
Cash Flows from Investing Activities | ||||||||||
Principal deposited in Trust Account | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Interest released from Trust Account | ||||||||||
-40,050 | -250,000 | -250,000 | -471,467 | -200,250 | - | - | - | - | - | 0 |
Net cash provided by investing activities | ||||||||||
40,050 | 250,000 | 250,000 | 471,467 | 200,250 | - | - | - | - | - | 0 |
Cash Flows from Financing Activities: | ||||||||||
Proceeds from note payable to related parties | ||||||||||
430,000 | 0 | 350,000 | 0 | 400,000 | 0 | 0 | 160,000 | 100,000 | 200,000 | 0 |
Repayment of note payable to related parties | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Proceeds received from initial public offering | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Offering costs | ||||||||||
- | - | - | - | - | 54,686 | 322,205 | 3,255,109 | 39,204 | 123,597 | 0 |
Proceeds received from private placement | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Issuance of Class B common stock to Sponsor, shares | ||||||||||
- | - | - | - | - | - | - | - | - | 25,000 | 25,000 |
Net cash provided by financing activities | ||||||||||
430,000 | 0 | 350,000 | 0 | 400,000 | -54,686 | -322,205 | 159,454,891 | 60,796 | 76,403 | 25,000 |
Net increase in cash and cash equivalents | ||||||||||
224,355 | -169,165 | 151,152 | -253,873 | 236,487 | -190,941 | -519,293 | 902,940 | -15,440 | -4,782 | 24,320 |
Supplemental disclosure of noncash investing and financing activities: | ||||||||||
Offering costs included in accounts payable | ||||||||||
- | - | - | - | - | 0 | -202,139 | 259,157 | 10,124 | 24,686 | 25,000 |
Offering costs included in accrued expenses | ||||||||||
- | - | - | - | - | - | - | 1,500 | 38,500 | -69,220 | 74,220 |
Deferred underwriting commissions in connection with the initial public offering | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Reclassification of deferred offering costs to paid-in capital | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Change in value of Class A common stock subject to possible redemption | ||||||||||
22,750 | 305,187 | 477,196 | 526,960 | 462,489 | - | - | - | - | - | 0 |